Related Experiment Video
Updated: Jun 19, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot study
R Pellicano1, S Strona, D Simondi
1University Department of Gastro-Hepathology, Molinette Hospital, Turin, Italy. rinaldo_pellican@hotmail.com
This study found that a dietary supplement significantly improved symptoms in patients with functional dyspepsia. The supplement, containing alginate, bicarbonate, bromelin, and essential oils, offers an alternative to antacid therapy.
Area of Science:
- Gastroenterology
- Pharmacology
- Dietary Supplements
Background:
- Functional dyspepsia (FD) has a complex pathogenesis, necessitating alternative treatments beyond antacids.
- Current therapeutic strategies for FD often focus on symptom management, with varying degrees of success.
Purpose of the Study:
- To evaluate the efficacy of a dietary integrator composed of sodium alginate, sodium bicarbonate, bromelin, and essential oils in treating functional dyspepsia.
- To assess the impact of the supplement on symptom improvement in FD patients negative for Helicobacter pylori infection.
Main Methods:
- A prospective study involving 53 consecutive patients diagnosed with functional dyspepsia and H. pylori negative.
- Patients were categorized by predominant symptom (ulcer-like, motility-like, reflux-like, nonspecific) and treated with TUBES gastro (0.80 g oral tablets bid) for at least 3 months.
- Treatment efficacy was quantified using the Visual Analogue Scale (VAS).
Main Results:
- Out of 51 patients who completed the study, 35 (68%) reported improvement in their VAS scores.
- A statistically significant reduction in VAS scores was observed, with a mean difference of -1.9+/-2.1 cm (P=0.0001).
- The overall improvement in dyspeptic symptoms was 23.8+/-40.8% compared to baseline.
Conclusions:
- The dietary integrator TUBES gastro demonstrated significant short-term efficacy in improving dyspeptic symptoms in H. pylori negative patients.
- The observed benefits are attributed to the synergistic action of its components: alginate for acid buffering, bicarbonate for pH balance, essential oils for motility regulation, and bromelin for enzymatic stimulation.
- This formulation presents a promising alternative therapeutic strategy for managing functional dyspepsia.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Treatment of Constipation-Predominant IBS
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...